Skip to main content
. Author manuscript; available in PMC: 2011 Jan 22.
Published in final edited form as: Brain Res. 2009 Nov 27;1311:28–36. doi: 10.1016/j.brainres.2009.11.048

Figure 4.

Figure 4

In panels A, NT69L blocked the PCP-induced increase of glutamate levels in mPFC. In panels B, NT69L significantly increased glycine levels in mPFC in both NT69L/Saline group and NT69L/PCP group. All data are shown as % baseline of amino acids measured every 20 min (±S.E.M.). (N=5 for PCP group, Saline/Saline group and NT69L/Saline group, N=6 for NT69L pretreated group). *, P<0.05 NT69L treated groups versus Saline treated groups. @, P<0.05 versus Saline/Saline and NT69L/PCP groups. $, P<0.05 versus Saline/Saline, and Saline/PCP groups. Gray arrow indicates when rats received either saline or NT69L injection. Black arrow indicates when rats received either saline or PCP injection.